1 option
Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis / Canadian Agency for Drugs and Technologies in Health, issuing body.
- Format:
- Book
- Series:
- Common drug review clinical review report.
- Common drug review
- Language:
- English
- Subjects (All):
- Monoclonal antibodies--Therapeutic use.
- Monoclonal antibodies.
- Rheumatoid arthritis--Treatment.
- Rheumatoid arthritis.
- Physical Description:
- 1 online resource.
- Other Title:
- Golimumab
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, [2015]
- Notes:
- Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis.
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.